SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR Dow Jones Industrial Average ETF Trust

The SPDR Dow Jones Industrial Average ETF is experiencing a significant rally amid reports and community chatter suggesting a potential de-escalation or end to the Iran war, which is also driving a sharp drop in oil prices and sparking discussions of a broad market short squeeze among traders.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending as its Q4 earnings massively exceeded expectations, propelling an after-hours surge and reinforcing community optimism about Miplyffa's strong growth trajectory and imminent European regulatory approval.

Brand Engagement Network, Inc. engages in the provision of conversational artificial intelligence assistants with the purpose of transforming engagement and analytics for businesses through security-focused, multimodal communication and human-like artificial intelligence assistants. The firm is also involved in delivering highly personalized, multi-modal artificial intelligence engagement with a focus on industries where there is a massive workforce gap and an opportunity to transform how consumers engage with networks, providers, and brands. The company is founded on March 14, 2024 and is headquartered in Jackson, WY.

Brand Engagement Network Inc

Brand Engagement Network Inc. ($BNAI) is experiencing intense community interest following the recent closing of a significant AI licensing partnership in Africa, which bulls are pointing to as a catalyst for a massive short squeeze. With extremely high cost-to-borrow rates and a low float, the stock is drawing fervent speculation for substantial upside amidst a "no-sell" movement among eager retail traders.

Americas Gold & Silver Corp. engages in the acquisition, exploration, development, and exploration of mineral resource properties. It operates through the following segments: Cosalá Operations, Galena Complex, Relief Canyon, and Corporate and Other. The Cosalá Operations segment operates in Mexico. The Galena Complex and Relief Canyon segments focuses on the United States. The company was founded by Peter Jude Hawley on May 12, 1998 and is headquartered in Toronto, Canada.

Americas Gold and Silver Corp

Americas Silver Corp

Americas Silver Corp is heavily discussed as its joint venture with US Antimony aims to boost domestic production of the critical mineral, while investors keenly watch for the stock to reflect the ongoing historic surge in silver prices, which many in the community believe is being suppressed by market manipulation.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is trending amidst strong community anticipation for pivotal Phase 3 REGAL trial results for its GPS immunotherapy in AML, especially after the CEO's recent comments hinting at "curative outcomes." This fuels widespread speculation of an imminent Big Pharma buyout and a significant short squeeze, contrasting sharply with minority skepticism regarding the trial's blinded status and valuation.

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Aldeyra Therapeutics Inc

Aldeyra Therapeutics is trending due to its upcoming March 16 PDUFA date for dry eye treatment reproxalap, following a three-month FDA extension to review additional field trial data, which has intensely polarized community sentiment. Bulls highlight a previously received draft label and the drug's rapid efficacy, while bears emphasize two prior Complete Response Letters, a recent executive resignation, and concerns over the company's financial runway.

Draganfly, Inc. engages in the manufacture and sale of commercial unmanned aerial vehicle systems and software serving the public safety, agriculture, industrial inspections, security, mapping, and surveying markets. Its products include quad-copters, fixed wing aircrafts, ground based robots, hand held controllers, and software used for tracking, live streaming, and data collection. The firm also offers custom engineering, training, simulation consulting, as well as data and flight training services. The company was founded by Zenon Dragan and Christine Dragan in 1998 and is headquartered in Saskatoon, Canada.

Draganfly Inc

Draganfly (DPRO) is drawing significant attention from new defense contracts, including an international military order and providing drones to U.S. Air Force Special Operations, amplified by prospects from Canada's substantial defense industrial strategy. Community discussion balances enthusiasm for its role in a growing drone sector against concerns over a recent capital raise and not being selected for the DoD's initial Gauntlet I program.

Bittensor is an open-source protocol that powers a decentralized, blockchain-based machine learning network. Machine learning models train collaboratively and are rewarded in TAO according to the informational value they offer the collective. TAO also grants external access, allowing users to extract information from the network while tuning its activities to their needs.  Ultimately, BitTensors vision is to create a pure market for artificial intelligence, an incentivized arena in which consumers and producers of this valuable commodity can interact in a trustless, open and transparent context.  Bittensor enables:  -A novel, optimized strategy for the development and distribution of artificial intelligence technology by leveraging the possibilities of a distributed ledger. Specifically, its facilitation of open access/ownership, decentralized governance, and the ability to harness globally-distributed resources of computing power and innovation within an incentivized framework.  -An open-source repository of machine intelligence, accessible to anyone, anywhere, thus creating the conditions for open and permission-less innovation on a global internet scale.  -Distribution of rewards and network ownership to users in direct proportion to the value they have added.

Bittensor

Bittensor (TAO CRYPTO) is trending amid anticipation of its upcoming halving and Grayscale's ETF filing, driving extensive community debate over its potential as the "Bitcoin of AI" and its role in building decentralized intelligence infrastructure.

Unusual Machines, Inc. is a development stage technology company, which engages in the provision of drone solutions with a focus on first-person view (FPV) technology. It offers products to entertainment, recreation, and competitive racing industries. The company was founded on July 11, 2019, and is headquartered in Orlando, FL.

Unusual Machines Inc

Unusual Machines is generating significant buzz due to a recent $2.1 million defense order and its strategic investment in the Trump-backed XTEND merger, reinforcing its pivotal role in the expanding domestic drone industry. The community is keenly anticipating government contracts from the Drone Dominance Program, highlighting UMAC's low float, NDAA-compliant components, and potential for a substantial short squeeze.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is seeing a strong rebound, propelled by President Trump's comments suggesting the Iran war is "very complete" and oil prices sharply reversing. This has sparked a "V pump" celebration among bulls, while skeptics on the other side decry it as a market "manipulation" disconnected from the ongoing geopolitical situation and underlying economic risks.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
